Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Security class unavailable · CUSIP: 037326105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-044249
- Form type
- SC 13G
- Filer
- AN2 Therapeutics, Inc.
- CIK
- CIK 1880438
- Filed
- Apr 08, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership